548 results on '"Patt, Marianne"'
Search Results
2. Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer
3. Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework
4. The revision of the pharmaceutical legislation — it is time to act for nuclear medicine in Europe
5. Highlight selection of radiochemistry and radiopharmacy developments by editorial board
6. Tau deposition patterns are associated with functional connectivity in primary tauopathies
7. Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings
8. Additive value of [18F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
9. Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
10. Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January-June 2020).
11. Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study
12. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [18F]-PI-2620 tau-PET signal
13. EANM guideline on quality risk management for radiopharmaceuticals
14. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre
15. EANM position on the in-house preparation of radiopharmaceuticals
16. Cerebral Blood Flow Measurement with Oxygen-15 Water Positron Emission Tomography
17. Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [18F]PI-2620.
18. Central Noradrenergic Neurotransmission and Weight Loss 6 Months After Gastric Bypass Surgery in Patients with Severe Obesity
19. Ions and small molecules as radiopharmaceuticals
20. Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
21. Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
22. (+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls
23. Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer.
24. First Safety and Efficacy Data with the Radiohybrid177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
25. Noradrenergic control of neurobehavior in human binge‐eating disorder and obesity (NOBEAD): A smartphone‐supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging
26. Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
27. Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
28. First Safety and Efficacy Data with the Radiohybrid 177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer.
29. Noradrenergic control of neurobehavior in human binge‐eating disorder and obesity (NOBEAD): A smartphone‐supported behavioral emotion regulation intervention study protocol integrating molecular brain imaging.
30. Cerebral Blood Flow Measurement with Oxygen-15 Water Positron Emission Tomography
31. Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity
32. The association between in vivo central noradrenaline transporter availability and trait impulsivity
33. Gastric Bypass Surgery Recruits a Gut PPAR-α-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats
34. EANM guideline on the validation of analytical methods for radiopharmaceuticals
35. Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study
36. Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults
37. Die „sachkundige Person“ in der Radiopharmazie – Herstellungserlaubnis oder nicht?
38. Increase in serotonin transporter binding in patients with premenstrual dysphoric disorder across the menstrual cycle: a case-control longitudinal neuroreceptor ligand PET imaging study
39. In-vivo serotonin transporter availability and somatization in healthy subjects
40. Cerebral Blood Flow Measurement with Oxygen-15 Water Positron Emission Tomography
41. Radionuclides: medicinal products or rather starting materials?
42. Current radiotracers to image neurodegenerative diseases
43. Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings
44. Subcortical tau‐accumulation predicts neuronal dysfunction in the cortex based on functional connectivity in 4R‐tauopathies
45. Availability of Central α4β2* Nicotinic Acetylcholine Receptors in Human Obesity
46. Central Serotonin/Noradrenaline Transporter Availability and Treatment Success in Patients with Obesity
47. HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
48. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET
49. Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β
50. Test–retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.